Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review-Reference-Cited by-同舟云学术

Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review

Published:2016-08-24 Issue:1 Volume:14 Page:
ISSN:1477-7819
Container-title:World Journal of Surgical Oncology
language:en
Short-container-title:World J Surg Onc

Author:

Ashby Lynn S.,Smith Kris A.,Stea Baldassarre

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1186/s12957-016-0975-5

Reference50 articles.

1. Watanabe M, Tanaka R, Takeda N. Magnetic resonance imaging and histopathology of cerebral gliomas. Neuroradiology. 1992;34:463–9.

2. Stewart LA. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet. 2002;359:1011–8.

3. Black PM. Brain tumors. Part 1. N Engl J Med. 1991;324:1471–6.

4. Black PM. Brain tumor. Part 2. N Engl J Med. 1991;324:1555–64.

5. Brem H, Piantadosi S, Burger PC, Walker M, Selker R, Vick NA, et al. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group. Lancet. 1995;345:1008–12.

Cited by 146 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Local delivery of carboplatin-loaded hydrogel and calcium carbonate enables two-stage drug release for limited-dose radiation to eliminate mouse malignant glioma;Biomaterials;2025-01

2. The potential of exosomes as a new therapeutic strategy for glioblastoma;European Journal of Pharmaceutics and Biopharmaceutics;2024-10

3. An injectable biomimetic hydrogel adapting brain tissue mechanical strength for postoperative treatment of glioblastoma without anti-tumor drugs participation;Journal of Controlled Release;2024-09

4. Targeted delivery of nanomedicines to glioblastoma: Overcoming the clinical barrier;Journal of Drug Delivery Science and Technology;2024-09

5. Role of Scaffold Proteins in the Heterogeneity of Glioblastoma;2024-07-29